Author

Tom Edmonds

Observed names: Edmonds T., T Edmonds, T. Edmonds

OpenAlex ID: A5004279222

EE101 Estimating the Burden of Osteogenesis Imperfecta on Patients and Healthcare Payers: A Health Economic Modelling Study

2024 · T Edmonds, O Darlington, et al. · Value in Health · 1

HTA117 A Comparison of Health Technology Appraisal (HTA) Timelines and Requirements for Orphan Technologies in 10 European Countries

2023 · A. Mumford, G. Roberts, et al. · Value in Health · 1

HTA39 Estimating the True Cost of Weight-Based Chemotherapy

2022 · T Edmonds, G Roberts, et al. · Value in Health · 1

Eph126 Estimatingthe Effects of Varied Vaccination Coverage Levels on a Measles Outbreak in an Isolated Population

2026 · Tom Edmonds, Oliver T. Darlington, et al. · Value in Health

Sparsentan for the Treatment of Immunoglobulin A Nephropathy: An Innovative Concept for Economic Modelling

2026 · Baxter G., Ramirez de Arellano A., et al. · Journal of Clinical Medicine

EE17 A Cost-Utility Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in the UK

2025 · Antonio Ramirez de Arellano Serna, Garth Baxter, et al. · Value in Health

HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis

2025 · Charlotte Ahmadu, Tom Edmonds, et al. · Value in Health

EE202 Conceptualization and Validation of a Health Economic Model for Osteogenesis Imperfecta

2024 · T Edmonds, O Darlington, et al. · Value in Health

EE516 Estimating the Benefits of Reduced Fracture Incidence for Patients Living with Osteogenesis Imperfecta and for Healthcare Payers

2024 · T Edmonds, O Darlington, et al. · Value in Health

EE761 The Impact of Differences in Patient Demographics on Assessment of Long-Term Cost-Effectiveness in Cohort Level Economic Models

2023 · T. Edmonds, A. Mumford, et al. · Value in Health

EE120 Cost-Effectiveness of Difelikefalin for the Treatment of Moderate to Severe Chronic Kidney Disease-Associated Pruritus (CKD-AP) in Adult Patients Receiving in-Centre Haemodialysis

2023 · C. Collins, T. Edmonds, et al. · Value in Health

RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)

2023 · T. Edmonds, E. Evers, et al. · Value in Health

HPR132 Pricing Variations between Early Access Prices and List Prices in Switzerland

2023 · T. Edmonds, D. Ringger, et al. · Value in Health

HTA262 Cost Effectiveness Analysis of Paclitaxel Micellar for Treatment of First Relapse Platinum Sensitive Ovarian Cancer

2022 · T Edmonds, B English, et al. · Value in Health

Works count: 14

Citation count: 3

H-index: 1

I10-index: